FMP
Predilife S.A.
ALPRE.PA
EURONEXT
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
4.3 EUR
0.22 (5.12%)
About
ceo
Mr. Stephane Ragusa
sector
Healthcare
industry
Medical - Diagnostics & Research
website
https://www.predilife.com
exchange
EURONEXT
Description
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
CIK
N/A
ISIN
FR0010169920
CUSIP
F8580W104
Address
39, Rue Camille Desmoulins
Phone
33 9 53 75 85 43
Country
FR
Employee
20
IPO Date
Dec 21, 2018
Key Executives
